Neil Fanger
CHAIRMAN AND CEO
immunology
Pfizer
United States of America
Biography
Neil Fanger has over 17 years of experience in the life sciences industry, spanning business development, product strategy, and biological research. Prior to Virtici, Dr. Fanger co-founded Teranode Corporation (acquired by Rage Frameworks in 2010). At Teranode, he led teams that introduced new products into the marketplace and secured worldwide partnerships with strategic customers such as Pfizer, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.
Research Interest
Prior to Teranode, Dr. Fanger focused on product development at Corixa and Immunex. Dr. Fanger is co-inventor on several patents covering novel biological therapeutics and software technologies, and co-author on numerous research publications in leading scientific journals. He earned a PhD in physiology from Dartmouth Medical School, and a BS in chemistry from Denison University.